Acute pancreatitis in an ulcerative colitis patient treated with vedolizumab and budesonide.
Ugeskr Laeger
; 186(22)2024 May 27.
Article
de Da
| MEDLINE
| ID: mdl-38847300
ABSTRACT
Acute pancreatitis (AP) is a sudden inflammation of the pancreas which often manifests as a mild disease but can be associated with high morbidity and mortality. Drug-induced AP is rare and most likely underdiagnosed. Vedolizumab is a human monoclonal antibody with gut-selective integrin antagonist effect, and it is used for treatment of inflammatory bowel disease (IBD). Budesonid is a glucocorticoid which is released in the colon and it is also used in IBD treatment. This is a case report where vedolizumab or budesonide caused acute pancreatitis in a young man with ulcerative colitis.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Pancréatite
/
Agents gastro-intestinaux
/
Rectocolite hémorragique
/
Budésonide
/
Anticorps monoclonaux humanisés
Limites:
Adult
/
Humans
/
Male
Langue:
Da
Journal:
Ugeskr Laeger
Année:
2024
Type de document:
Article